Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person During G1, the activity of cyclin-dependent kinases (CDKs) i...

Class:IdSummation:187936
_displayNameDuring G1, the activity of cyclin-dependent kinases (CDKs) i...
_timestamp2016-02-08 20:44:07
created[InstanceEdit:187964] Matthews, L, 2006-09-29 13:54:26
literatureReference[LiteratureReference:187850] Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
modified[InstanceEdit:8856093] Orlic-Milacic, Marija, 2016-02-08
textDuring G1, the activity of cyclin-dependent kinases (CDKs) is controlled by the CDK inhibitors (CKIs) CDKN1A (p21) and CDKN1B (p27), thereby preventing premature entry into S phase (Guardavaccaro and Pagano, 2006).
(summation)[Reaction:187934] Inactivation of Cyclin A:Cdk2 complexes by p27/p21 [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by During G1, the activity of cyclin-dependent kinases (CDKs) i... (187936)